Literature DB >> 28830214

Anti-Inflammatory and Immunostimulatory Activities of Astragalosides.

Yan Qi1, Feng Gao2, Lifei Hou3, Chunping Wan1.   

Abstract

Astragalus membranaceus (Fisch) Bge (Huang-Qi) is a well-known herbal medicine with tonic property and has been widely used to treat cancer and other immune disorders in China and Southeast Asia for thousands of years. Accumulating evidence suggests that Huang-Qi possesses both immune-boosting and anti-inflammatory/immune-regulatory effects clinically, leaving the mechanism elusive. Recently, we discovered that Astragaloside (ASI), a major active component of Huang-Qi, is able to increase CD45 phosphatase activity. In this paper, we reviewed the recent progress of ASIs in immunoregulatory and anti-inflammatory activities, including the induction of T-cell activation, regulation of effector/regulatory T-cell balance, enhancement of CD45 phosphatase activity, inhibition of pro-inflammatory cytokine and, NF-[Formula: see text]B pathway. Finally, we hypothesized that inducing interferon-[Formula: see text] (IFN-[Formula: see text]) activity by activating CD45 protein tyrosine phosphatase (PTPase) may be involved in the protective role of ASI in two contrary immune-associated diseases. These pharmacological properties highlight the traditional uses of Astragalus and provide a new direction for subsequent research and the clinical application of this traditional herbal.

Entities:  

Keywords:  Anti-Inflammatory; Astragalosides; CD45PTPase; Immunostimulatory; Interferon-; Review

Mesh:

Substances:

Year:  2017        PMID: 28830214     DOI: 10.1142/S0192415X1750063X

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  30 in total

Review 1.  Evidence-Based Immunotherapeutic Effects of Herbal Compounds on Humoral Immunity: Ancient and New Approaches.

Authors:  Fatemeh Nejatbakhsh; Mohammad Ali Zareian; Mahdi Yaseliani; Hassan Abolhassani
Journal:  Chin J Integr Med       Date:  2021-03-24       Impact factor: 1.978

2.  Efficacy and Safety of Ganduqing Granules in Treating the Common Cold: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yilan Wang; Piao Zhou; Yuxiao Wu; Huaqin Cao; Wenfeng Hao; Fei Wang; Jing Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-09       Impact factor: 2.650

3.  Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats.

Authors:  Dong Han
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

4.  The Role of Endophytic/Epiphytic Bacterial Constituents in the Immunostimulatory Activity of the Botanical, Astragalus membranaceus.

Authors:  Heather Koehler; Keely Puchalski; Guillermo Ruiz; Bertram Jacobs; Jeffrey Langland
Journal:  Yale J Biol Med       Date:  2020-06-29

5.  Microgravity versus Microgravity and Irradiation: Investigating the Change of Neuroendocrine-Immune System and the Antagonistic Effect of Traditional Chinese Medicine Formula.

Authors:  Haoru Zhu; Lin Zhang; Meng Qian; Tuo Shi; Fangxin Fan; Wenfei Li; Sitai Zhu; Ming Xie
Journal:  Biomed Res Int       Date:  2020-05-26       Impact factor: 3.411

Review 6.  How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?

Authors:  Zhendong Feng; Wenbin Liu; Han Xue Jiang; Haoran Dai; Chang Gao; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Qihan Zhao; Lei Zhang; Baoli Liu
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

Review 7.  Recent Advances in Herbal Medicines for Digestive System Malignancies.

Authors:  Jiyao Sheng; Xiaohan Zou; Ziqian Cheng; Yien Xiang; Wei Yang; Yang Lin; Ranji Cui
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

8.  Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Authors:  Patrick M Honore; David De Bels; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2018-09-27       Impact factor: 6.925

9.  Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.

Authors:  Xuan Xia; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie C Xue; Qingchun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

10.  Tou Nong San Attenuates Inflammation in TNBS-IBD Model by Inhibiting NF-κB Signaling Pathway.

Authors:  Zhipeng Hu; Maoyi Yang; Qiaobo Ye; Kaihua Qin; Mingquan Wu; Rui Gu; Yingguang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.